Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

This study is currently recruiting participants.
Information provided by University of California, San Francisco

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Frontal Lobe Dementia
			Frontotemporal Lobe Dementia
			Semantic Dementia
2		Additional conditions recognized in this trial
			Aphasia, Primary Progressive
			Dementia
			Pick Disease of the Brain
3		More general conditions related to this trial
			Aphasia
			Brain Diseases
			Central Nervous System Diseases
			Communication Disorders
			Delirium, Dementia, Amnestic, Cognitive Disorders
			Language Disorders
			Mental Disorders
			Nervous System Diseases
			Neurobehavioral Manifestations
			Neurologic Manifestations
			Signs and Symptoms
			Speech Disorders
4		Interventions listed in this trial
			memantine
			Placebo pill
5		More general drug interventions related to this trial
			Anti-Dyskinesia Agents
			Antiparkinson Agents
			Central Nervous System Agents
			Dopamine Agents
			Excitatory Amino Acid Agents
			Excitatory Amino Acid Antagonists
			Molecular Mechanisms of Pharmacological Action
			Neurotransmitter Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
6		Sponsors listed in this trial
			University of California, San Francisco
			Forest Laboratories